These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 35151716

  • 1. Response to the letter by Zhang et al. "Neuropeptide Y - A potential therapeutic target in cardiac remodeling".
    Zaglia T, Mongillo M.
    Int J Cardiol; 2022 Apr 01; 352():123. PubMed ID: 35151716
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nur77 protects against adverse cardiac remodelling by limiting neuropeptide Y signalling in the sympathoadrenal-cardiac axis.
    Medzikovic L, van Roomen C, Baartscheer A, van Loenen PB, de Vos J, Bakker ENTP, Koenis DS, Damanafshan A, Creemers EE, Arkenbout EK, de Vries CJM, de Waard V.
    Cardiovasc Res; 2018 Oct 01; 114(12):1617-1628. PubMed ID: 29850786
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Effects of Neuropeptide Y Overexpression on the Mouse Model of Doxorubicin-Induced Cardiotoxicity.
    Mattila M, Söderström M, Ailanen L, Savontaus E, Savontaus M.
    Cardiovasc Toxicol; 2020 Jun 01; 20(3):328-338. PubMed ID: 31811615
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-Term Administration of Neuropeptide Y in the Subcutaneous Infusion Results in Cardiac Dysfunction and Hypertrophy in Rats.
    Zhang R, Niu H, Kang X, Ban T, Hong H, Ai J.
    Cell Physiol Biochem; 2015 Jun 01; 37(1):94-104. PubMed ID: 26303143
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of neuropeptide Y and its analogues on inositol 1,4,5-trisphosphate level in rat cardiomyocytes.
    Xiang H, Brown JC.
    Recept Channels; 1993 Jun 01; 1(4):315-21. PubMed ID: 8081728
    [Abstract] [Full Text] [Related]

  • 17. Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload.
    Bell D, Allen AR, Kelso EJ, Balasubramaniam A, McDermott BJ.
    J Pharmacol Exp Ther; 2002 Nov 01; 303(2):581-91. PubMed ID: 12388639
    [Abstract] [Full Text] [Related]

  • 18. The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte.
    Piper HM, Millar BC, McDermott BJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep 01; 340(3):333-7. PubMed ID: 2554154
    [Abstract] [Full Text] [Related]

  • 19. Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes.
    Balasubramaniam A, Sheriff S, Rigel DF, Fischer JE.
    Peptides; 1990 Sep 01; 11(3):545-50. PubMed ID: 2166278
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.